Please Wait
Applying Filters...
menu
    • menu
    FDA okays 50 new drugs in 2024; BMS’ Cobenfy, Lilly’s Kisunla lead pack of breakthrough therapies

    Data Compilation
    #PharmaFlow

    Pipeline Prospector Jan 2025: J&J’s US$ 14.6 bn Intra-Cellular buyout kicks off deal frenzy; Ozempic clinches FDA nod for CKD

    Stock Recap
    #PipelineProspector

    Menu

    Cefadroxil

    ACTIVE PHARMA INGREDIENTS

    INTERMEDIATES

    FINISHED DOSAGE FORMULATIONS

    RELATED EXCIPIENT COMPANIES

    EXCIPIENTS BY APPLICATIONS

    DIGITAL CONTENT

    GLOBAL SALES INFORMATION

    MARKET PLACE

    REF. STANDARDS & IMPURITIES

    ANALYTICAL

    PharmaCompass
    $ API Ref.Price (USD/KG) : 68Xls download

    Filters

    clear-filterReset all filters
    ListList of Suppliers
    refreshReset Filter
    refresh Reset Filter
    Price Info Price Info
    product-page Product Main Page

    Data in the table can be downloaded after upgrading. In the meantime, you can access the data through the menu.

    Last Updated on PharmaCompass Virtual Booth Country Registrant Name Registration No. Compound Registration Date Manufacturer Manufacturer's Country Manufacturer's Address
    30/12/2024 Centrient Pharmaceuticals
    Netherlands
    		 Daewoong Bio Co., Ltd. 20050831-19-A-15-05(3) Cefadroxil hydrate 2019-04-04 Centrient Pharmaceuticals Spain S.A. Spain C/Ripolles, n2 Poligono Industrial URVASA Santa Perpetua de Mogoda 08130 BARCELONA SPAIN (POBox 425, 2600 AK Delft, The Netherlands)
    30/12/2024 Centrient Pharmaceuticals
    Netherlands
    		 Daewoong Pharmaceutical Co., Ltd. 20050831-19-A-15-05(2) Cefadroxil hydrate 2015-05-12 Centrient Pharmaceuticals Spain S.A. Spain C/Ripolles, n2 Poligono Industrial URVASA Santa Perpetua de Mogoda 08130 BARCELONA SPAIN (POBox 425, 2600 AK Delft, The Netherlands)